SCHEMBL2836692

SCHEMBL2836692

CN1CCC(Oc2ccc(Br)c(Br)c2)c2occc2C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
RYR2 Q92736 1/20 0.32
DRD1 P21728 1/20 0.32
DRD5 P21918 1/20 0.32
MCHR1 Q99705 2/20 0.31
ALDH1A1 P00352 2/20 0.31
ACHE P22303 3/20 0.31
HRH3 Q9Y5N1 1/20 0.31
BCHE P06276 1/20 0.31
CHRNA3 P32297 1/20 0.31
GAA P10253 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
ATM Q13315 1/20 0.30
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837126 0.83 HRH3 (0.39) DRD1DRD5ALDH1A1HRH3CHRNA3
SCHEMBL2838001 0.83 KDM4E (0.38) ALDH1A1CHRNA3
SCHEMBL2868853 0.81 ROCK2 (0.32) ROCK2MAOAMAOBMCHR1ALDH1A1
SCHEMBL2841183 0.79 HTR2A (0.40) MCHR1ALDH1A1HRH3HTR2AHTR2C
SCHEMBL2840421 0.78 PKM (0.34) MAOAMAOBACHEBCHEL3MBTL1
Hydrochloric Acid SCHEMBL2835085 0.75 RYR2 (0.34) ROCK2RYR2DRD1DRD5MCHR1
SCHEMBL2838705 0.73 MAOA (0.34) ROCK2MAOAMAOBMCHR1CHRNA3
Citric Acid SCHEMBL2835076 0.72 KDM4E (0.38) ALDH1A1
Hydrochloric Acid SCHEMBL2835850 0.72 MAOA (0.34) ROCK2MAOAMAOBMCHR1ALDH1A1
SCHEMBL2839442 0.71 SLC6A4 (0.38) ALDH1A1HRH3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 ROCK2 2445/4885MAOA 16/4885MAOB 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.